Dr. Samuel Constant, Ph.D, COO, Co-Founder of Epithelix, is a synthetic organic chemist, with 12 years of research experiences in several countries (Switzerland, France, UK and Japan). He also has expertise in in vitro test method development. He is in charge of the Management, Business Development and Partnership of the company. Samuel is also CEO of OncoTheis.
Partnership, Business Development, Strategy, Finance, Project Management, in vitro Method Development